Probiotics mixture suppresses MASLD-associated hepatocellular carcinoma
Probiotics mixture suppresses MASLD-associated hepatocellular carcinoma and potentiates the effects of low-dose Sorafenib in DEN-HFD induced HCC mice model via gut microbiome modulation and SCFAs production